Quantum computing roundup: Still more technologies making waves

Quantum computing hardware development continues to move in multiple directions. While many focus on massive qubit counts, recent breakthroughs in silicon-based quantum dots and diamond defects show that researchers are prioritizing different paths to reach large-scale, reliable computation.

HRL Laboratories recently published work on a new qubit control system. Instead of relying on complex microwave wiring, their approach uses electronic control of electron spins in silicon. This method reduces the heat load on cryogenic systems by keeping control electronics at intermediate temperatures, successfully managing eighteen qubits with a logical error rate under one percent. IBM has since acquired this technology to supplement its existing superconducting qubit portfolio.

Simultaneously, researchers at Delft University of Technology are testing a method for moving electron spins between quantum dots. This bus-like architecture allows qubits to be relocated across a chip, providing the flexibility to adapt error-correction codes based on runtime needs rather than hard-wired geometry. The team demonstrated high-fidelity spin transfer, showing that manufactured silicon components can achieve the reconfigurability previously found only in trapped-ion systems.

Meanwhile, Saxon Q is pursuing a different route using nitrogen-vacancy centers in diamonds. By controlling the placement of these impurities within a ten-nanometer radius, the company has developed a modular quantum processor that operates at room temperature. With over one hundred qubits per unit, this hardware avoids the extreme refrigeration requirements that define many other quantum platforms. While these systems are currently small, the combination of high gate fidelity and room-temperature operation presents a distinct alternative for future architecture design. The field remains divided on which hardware foundation will win, but these diverse approaches prove that no single design has claimed victory yet.